OneMedNet (NASDAQ:ONMD) CFO Sells $16,500.00 in Stock

OneMedNet Corporation (NASDAQ:ONMD) CFO Robert Golden sold 2,500 shares of OneMedNet stock in a transaction on Monday, September 14th. The stock was sold at an average price of $6.60, for a total transaction of $16,500.00. Following the sale, the chief financial officer directly owned 97,291 shares of the company’s stock, valued at approximately $642,120.60. This trade represents a 2.51% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Robert Lawrence Golden also recently made the following trade(s):

• On Monday, September 21st, Robert Golden sold 3,000 shares of OneMedNet stock. The stock was sold at an average price of $6.63, for a total transaction of $19,890.00.
• On Tuesday, September 15th, Robert Golden sold 3,000 shares of OneMedNet stock. The stock was sold at an average price of $6.30, for a total transaction of $18,900.00.

OneMedNet Price Performance

NASDAQ:ONMD opened at $4.75 on Friday. The business’s fifty day moving average price is $6.03 and its 200 day moving average price is $7.19. OneMedNet Corporation has a 12 month low of $3.61 and a 12 month high of $28.20.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings raised OneMedNet from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Monday, August 24th. One equities research analyst has rated the stock with a Sell rating. Based on data from MarketBeat, OneMedNet has a consensus rating of “Sell”.

About OneMedNet

OneMedNet Corporation is a healthcare technology company that develops infrastructure for accessing, managing and analyzing medical data. Its platform is designed to help healthcare providers, researchers, life sciences companies and other authorized users work with clinical and medical-imaging information while keeping the underlying data within the organization that controls it.

The company’s technology uses a federated data model, allowing participating institutions to collaborate on data analysis without routinely transferring sensitive patient information to a centralized repository.